The role of optical coherence tomography in multiple sclerosis: Expert panel consensus

[1]  J. De Keyser,et al.  Treatment with interferon beta-1b delays conversion to clinically definite and McDonald MS in patients with clinically isolated syndromes , 2006, Neurology.

[2]  Jeffrey M. Liebmann,et al.  Imaging of the optic disc and retinal nerve fiber layer in acute optic neuritis , 2006, Journal of the Neurological Sciences.

[3]  R. Kardon,et al.  Quantifying axonal loss after optic neuritis with optical coherence tomography , 2006 .

[4]  S. Anand Trip,et al.  Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: Evidence that axonal loss is a substrate of MRI-detected atrophy , 2006, NeuroImage.

[5]  Gareth J. Barker,et al.  Optic nerve diffusion tensor imaging in optic neuritis , 2006, NeuroImage.

[6]  Gary R Cutter,et al.  Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. , 2006, Ophthalmology.

[7]  R. Sergott,et al.  Optical coherence tomography: measuring in-vivo axonal survival and neuroprotection in multiple sclerosis and optic neuritis , 2005, Current opinion in ophthalmology.

[8]  Stephen J. Jones,et al.  Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis , 2005, Annals of neurology.

[9]  J. Corbett Experience of the optic neuritis treatment trial , 2004, Current Neurology and Neuroscience Reports.

[10]  G. Wollstein,et al.  Reproducibility of nerve fiber thickness, macular thickness, and optic nerve head measurements using StratusOCT. , 2004, Investigative ophthalmology & visual science.

[11]  Gadi Wollstein,et al.  Imaging in glaucoma. , 1996, Ophthalmology clinics of North America.

[12]  M. Maguire,et al.  Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite , 2003, Neurology.

[13]  Michael Wall,et al.  High- and low-risk profiles for the development of multiple sclerosis within 10 years after optic neuritis: experience of the optic neuritis treatment trial. , 2003, Archives of ophthalmology.

[14]  M Rovaris,et al.  Evidence for widespread axonal damage at the earliest clinical stage of multiple sclerosis. , 2003, Brain : a journal of neurology.

[15]  Robert W Knighton,et al.  Macular thickness changes in glaucomatous optic neuropathy detected using optical coherence tomography. , 2002, Archives of ophthalmology.

[16]  Anthony J Correnti,et al.  Optical coherence tomography measurement of macular and nerve fiber layer thickness in normal and glaucomatous human eyes. , 2003, Ophthalmology.

[17]  D. Miller,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Management of Acute Optic Neuritis , 2022 .

[18]  S J Hickman,et al.  Continuing optic nerve atrophy following optic neuritis: a serial MRI study , 2002, Multiple sclerosis.

[19]  S. Cole,et al.  Interferon β‐1a for early multiple sclerosis: CHAMPS trial subgroup analyses , 2002 .

[20]  J. Chan Optic neuritis in multiple sclerosis , 2002, Ocular immunology and inflammation.

[21]  P M Matthews,et al.  Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. , 2001, Brain : a journal of neurology.

[22]  Marco Rovaris,et al.  Effect of early interferon treatment on conversion to definite multiple sclerosis: a randomised study , 2001, The Lancet.

[23]  J. Fujimoto,et al.  Ultrahigh-resolution ophthalmic optical coherence tomography , 2001, Nature Medicine.

[24]  G. T. Plant,et al.  Detection of optic nerve atrophy following a single episode of unilateral optic neuritis by MRI using a fat-saturated short-echo fast FLAIR sequence , 2001, Neuroradiology.

[25]  L. Zangwill,et al.  Reproducibility of nerve fiber layer thickness measurements by use of optical coherence tomography. , 2000, Ophthalmology.

[26]  Josemir W Sander,et al.  The incidence and lifetime prevalence of neurological disorders in a prospective community-based study in the UK. , 2000, Brain : a journal of neurology.

[27]  L. Zangwill,et al.  The retinal nerve fiber layer thickness in ocular hypertensive, normal, and glaucomatous eyes with optical coherence tomography. , 2000, Archives of ophthalmology.

[28]  F Pierelli,et al.  Correlation between morphological and functional retinal impairment in multiple sclerosis patients. , 1999, Investigative ophthalmology & visual science.

[29]  H. Ishikawa,et al.  Increasing sampling density improves reproducibility of optical coherence tomography measurements. , 1999, Journal of glaucoma.

[30]  J. Frederiksen,et al.  Optic neuritis as onset manifestation of multiple sclerosis , 1999, Neurology.

[31]  P M Matthews,et al.  Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. , 1998, Brain : a journal of neurology.

[32]  G. McDonnell,et al.  An epidemiologic study of multiple sclerosis in Northern Ireland , 1998, Neurology.

[33]  R. Rudick,et al.  Axonal transection in the lesions of multiple sclerosis. , 1998, The New England journal of medicine.

[34]  P. Matthews,et al.  Imaging of axonal damage in multiple sclerosis: Spatial distribution of magnetic resonance imaging lesions , 1997, Annals of neurology.

[35]  P. Matthews,et al.  Chemical pathology of acute demyelinating lesions and its correlation with disability , 1995, Annals of neurology.

[36]  E A Swanson,et al.  Quantification of nerve fiber layer thickness in normal and glaucomatous eyes using optical coherence tomography. , 1995, Archives of ophthalmology.

[37]  L. Kurland,et al.  Optic neuritis , 1995, Neurology.

[38]  J. E. Rees,et al.  A prevalence survey of multiple sclerosis in Sussex. , 1995, Journal of neurology, neurosurgery, and psychiatry.

[39]  S. Lessell,et al.  Neuro-ophthalmology of multiple sclerosis. , 1994, Clinical neuroscience.

[40]  W. Mcdonald,et al.  The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[41]  K. Hyllested,et al.  Incidence of multiple sclerosis in Denmark 1948-1982: a descriptive nationwide study. , 1992, Neuroepidemiology.

[42]  E. Kinnunen The incidence of optic neuritis and its prognosis for multiple sclerosis , 1983, Acta neurologica Scandinavica.

[43]  N. Newman,et al.  Walsh and Hoyt's Clinical Neuro Ophthalmology , 1982 .

[44]  D. Shepherd,et al.  A further prevalence study of multiple sclerosis in north-east Scotland. , 1980, Journal of neurology, neurosurgery, and psychiatry.

[45]  L. Fischer The ocular manifestations of multiple sclerosis. , 1977, Journal of the American Optometric Association.

[46]  W. Hoyt,et al.  Subclinical optic neuropathy in multiple sclerosis. How early VER components reflect axon loss and conduction defects in optic pathways. , 1975, Journal of neurology, neurosurgery, and psychiatry.

[47]  L. Frisén,et al.  Insidious atrophy of retinal nerve fibers in multiple sclerosis. Funduscopic identification in patients with and without visual complaints. , 1974, Archives of ophthalmology.

[48]  Rolf Willanger,et al.  METAMORPHOPSIA AND OTHER VISUAL DISTURBANCES WITH LATENCY OCCURRING IN PATIENTS WITH DIFFUSE CEREBRAL LESIONS , 1966 .

[49]  H Miller,et al.  Neurological disease in an English city. , 1966, Acta neurologica Scandinavica.